GKOS Nov 2024 150.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 02:16PM EDT. Market open.
Loading interactive chart...
- Business Wire
Glaukos Announces Agreements to Exchange $230 Million in Principal Amount of Its 2.75% Convertible Senior Notes Due 2027 for Common Stock
ALISO VIEJO, Calif., June 14, 2024--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company, today announced that it entered into separate, privately negotiated exchange agreements (the "Exchange Agreements") with certain holders of its 2.75% Convertible Senior Notes due 2027 (the "Existing Convertible Notes"). Pursuant to these Exchange Agreements, the company agreed, subject to customary closing conditions, to repurchase an aggregate of $230 million princi
- Zacks
Why Is Waters (WAT) Down 5.1% Since Last Earnings Report?
Waters (WAT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
- Zacks
Glaukos (GKOS) Gains 40.4% YTD: What's Driving the Rally?
Investors are optimistic about Glaukos' (GKOS) strength in its flagship iStent.
© 2024 Yahoo. All rights reserved.